Metformin does not attenuate angiotensin II-induced aortic aneurysms in low-density lipoprotein receptor deficient mice
Samuel C. Tyagi, Sohei Ito, Jacob C. Hubbuch, Michael K. Franklin, Deborah A. Howatt, Hong S. Lu, Alan Daugherty, Hisashi Sawada · 2025
Read Metformin does not attenuate angiotensin II-induced aortic aneurysms in low-density lipoprotein receptor deficient mice by Samuel C. Tyagi, Sohei Ito, Jacob C. Hubbuch, Michael K. Franklin, Deborah A. Howatt, Hong S. Lu, Alan Daugherty, Hisashi Sawada (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12835021.txt.
Description
Samuel C Tyagi and co-authors report a negative result on a diabetes drug and aortic aneurysms in a 2025 study. Metformin had prevented aneurysms, dangerous bulges in the aorta, in one standard mouse model. A second model, lacking the receptor that clears fatty particles, mirrors human blood fats more closely and handles sugar differently.
Male mice of that strain drank metformin or plain water on a rich diet while a hormone infusion drove aneurysm formation for four weeks. Blood tests confirmed the drug was on board. In this strain, the protection vanished. The contrast warns that a drug's promise can depend on the model's metabolism.
Catalog record
| CREATOR | Samuel C. Tyagi, Sohei Ito, Jacob C. Hubbuch, Michael K. Franklin, Deborah A. Howatt, Hong S. Lu, Alan Daugherty, Hisashi Sawada |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |